Acknowledgement
This paper was supported by an NRF grant funded by the Korean government (NRF-2019R1A2C1004722) and Konkuk University Researcher Fund in 2022.
References
- Danielson PB (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3:561-597. https://doi.org/10.2174/1389200023337054
- Guengerich FP (2021) A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. Toxicol Res 37:1-23. https://doi.org/10.1007/s43188-020-00056-z
- Rendic S, Guengerich FP (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem Res Toxicol 28:38-42. https://doi.org/10.1021/tx500444e
- Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308:965-974. https://doi.org/10.1124/jpet.103.060137
- Lee YB, Kim V, Lee SG, Lee GH, Kim C, Jeong E, Kim D (2023) Functional characterization of allelic variations of human cytochrome P450 2C8 (V181I, I244V, I331T, and L361F). Int J Mol Sci 24:8032. https://doi.org/10.3390/ijms24098032
- Lee R, Kim V, Chun Y, Kim D (2021) Structure-functional analysis of human cytochrome P450 2C8 using directed evolution. Pharmaceutics 13:1429. https://doi.org/10.3390/pharmaceutics13091429
- Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70-83. https://doi.org/10.1021/tx700079z
- Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496-526. https://doi.org/10.1016/j.pharmthera.2007.09.004
- Wallmark B (1986) Mechanism of action of omeprazole. Scand J Gastroenterol Suppl 118:11-17. https://doi.org/10.3109/00365528609090881
- Chong E, Ensom MH (2003) Pharmacogenetics of the proton pump inhibitors: a systematic review. Pharmacotherapy 23:460-471. https://doi.org/10.1592/phco.23.4.460.32128
- Niwa T, Yasuda S, Yamamoto Y, Murakami M, Ishii R (2021) Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones. Pharmazie 76:611-613. https://doi.org/10.1691/ph.2021.1836
- Yamazaki H, Shimada T (1997) Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161-169. https://doi.org/10.1006/abbi.1997.0302
- White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291. https://doi.org/10.1210/edrv.21.3.0398
- Gomes LG, Huang N, Agrawal V, Mendonca BB, Bachega TA, Miller WL (2009) Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 94:89-95. https://doi.org/10.1210/jc.2008-1174
- Guengerich FP (2005) Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase. Arch Biochem Biophys 440:204-211. https://doi.org/10.1016/j.abb.2005.06.019
- Ozols J (1989) Structure of cytochrome b5 and its topology in the microsomal membrane. Biochim Biophys Acta 997:121-130. https://doi.org/10.1016/0167-4838(89)90143-x
- Kim D, Kim V, McCarty KD, Guengerich FP (2021) Tight binding of cytochrome b(5) to cytochrome P450 17A1 is a critical feature of stimulation of C21 steroid lyase activity and androgen synthesis. J Biol Chem 296:100571. https://doi.org/10.1016/j.jbc.2021.100571
- Gonzalez E, Guengerich FP (2017) Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1. J Biol Chem 292:13168-13185. https://doi.org/10.1074/jbc.M117.794917
- Lee SG, Kim V, Lee GH, Kim C, Jeong E, Guengerich FP, Kim D (2023) Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1). J Inorg Biochem 240:112085. https://doi.org/10.1016/j.jinorgbio.2022.112085
- Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T (2002) Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329-337. https://doi.org/10.1006/prep.2001.1578
- Park HG, Lim YR, Han S, Jeong D, Kim D (2017) Enhanced purification of recombinant rat NADPH-P450 reductase by using a hexahistidine-tag. J Microbiol Biotechnol 27:983-989. https://doi.org/10.4014/jmb.1701.01028
- Barnes HJ, Arlotto MP, Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A 88:5597-5601. https://doi.org/10.1073/pnas.88.13.5597
- Lee SA, Kim V, Choi B, Lee H, Chun YJ, Cho KS, Kim D (2023) Functional characterization of drosophila melanogaster CYP6A8 fatty acid hydroxylase. Biomol Ther (Seoul) 31:82-88. https://doi.org/10.4062/biomolther.2022.084
- Peng HM, Auchus RJ (2013) The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65. Biochemistry 52:210-220. https://doi.org/10.1021/bi301384n
- Locuson CW, Wienkers LC, Jones JP, Tracy TS (2007) CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis. Drug Metab Dispos 35:1174-1181. https://doi.org/10.1124/dmd.107.014910
- Yoo SE, Yi M, Kim WY, Cho SA, Lee SS, Lee SJ, Shin JG (2019) Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4. Drug Metab Pharmacokinet 34:201-208. https://doi.org/10.1016/j.dmpk.2019.03.001
- Kim D, Kim V, Tateishi Y, Guengerich FP (2021) Cytochrome b (5) binds tightly to several human cytochrome P450 enzymes. Drug Metab Dispos 49:902-909. https://doi.org/10.1124/dmd.121.000475
- Fekry MI, Xiao Y, Berg JZ, Guengerich FP (2019) A role for the orphan human cytochrome P450 2S1 in Polyunsaturated fatty acid omega-1 hydroxylation using an untargeted metabolomic approach. Drug Metab Dispos 47:1325-1332. https://doi.org/10.1124/dmd.119.089086
- Mizrachi D, Wang Z, Sharma KK, Gupta MK, Xu K, Dwyer CR, Auchus RJ (2011) Why human cytochrome P450c21 is a progesterone 21-hydroxylase. Biochemistry 50:3968-3974. https://doi.org/10.1021/bi102078e
- Lorence MC, Trant JM, Mason JI, Bhasker CR, Fujii-Kuriyama Y, Estabrook RW, Waterman MR (1989) Expression of a full-length cDNA encoding bovine adrenal cytochrome P450C21. Arch Biochem Biophys 273:79-88. https://doi.org/10.1016/0003- 9861(89)90164-1